Zoran Zdraveski

2023

In 2023, Zoran Zdraveski earned a total compensation of $1.6M as Chief Legal and Strategy Officer and Secretary at TScan Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$203,000
Option Awards$924,566
Salary$441,000
Other$13,200
Total$1,581,766

Zdraveski received $924.6K in option awards, accounting for 58% of the total pay in 2023.

Zdraveski also received $203K in non-equity incentive plan, $441K in salary and $13.2K in other compensation.

Rankings

In 2023, Zoran Zdraveski's compensation ranked 749th out of 3,006 executives tracked by ExecPay. In other words, Zdraveski earned more than 75.1% of executives.

ClassificationRankingPercentile
All
749
out of 3,006
75th
Division
Manufacturing
428
out of 1,650
74th
Major group
Chemicals And Allied Products
291
out of 918
68th
Industry group
Drugs
285
out of 881
68th
Industry
Biological Products, Except Diagnostic Substances
92
out of 213
57th
Source: SEC filing on April 30, 2024.

Zdraveski's colleagues

We found four more compensation records of executives who worked with Zoran Zdraveski at TScan Therapeutics in 2023.

2023

Gavin MacBeath

TScan Therapeutics

Chief Executive Officer

2023

Debora Barton

TScan Therapeutics

Chief Medical Officer

2023

Brian Silver

TScan Therapeutics

Chief Financial Officer

2023

David Southwell

TScan Therapeutics

Chief Executive Officer

News

In-depth

You may also like